HCW Biologics Closes Exclusive Worldwide License for HCW11-006 – A High Potential Fusion Immunotherapeutic
Go back to HCW Biologics Closes Exclusive Worldwide License for HCW11-006 – A High Potential Fusion Immunotherapeutic| (NASDAQ: HCWB) | Delayed: 1.08 -0.08 (6.9%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.16 | 52 Week High | $ | |||
| Open | $1.10 | 52 Week Low | $ | |||
| Day High | $1.15 | P/E | N/A | |||
| Day Low | $1.08 | EPS | $ | |||
| Volume | 291,054 | |||||
| (NASDAQ: HCWB) | Delayed: 1.08 -0.08 (6.9%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.16 | 52 Week High | $ | |||
| Open | $1.10 | 52 Week Low | $ | |||
| Day High | $1.15 | P/E | N/A | |||
| Day Low | $1.08 | EPS | $ | |||
| Volume | 291,054 | |||||

